Immunovaccine, Inc. (IMV):企業概要、財務及び戦略的SWOT分析

◆英語タイトル:Immunovaccine, Inc. (IMV) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH139059FSA
◆発行会社(調査会社):GlobalData
◆発行日:2015年1月9日
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD300 ⇒換算¥33,300見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD600 ⇒換算¥66,600見積依頼/購入/質問フォーム
Global Site License(複数国内共有可)USD900 ⇒換算¥99,900見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary

Immunovaccine, Inc. (IMV) is a biotechnology company. The company develops and markets vaccines for cancer therapy, infectious disease and animal health. Its products include DPX-0907, DPX-Survivac and infectious disease vaccines. The company’s DPX-0907 is a multi-targeted therapeutic cancer vaccine designed to train the immune system to recognize and attack cancer cells and DPX-Survivac is a clinical-stage cancer vaccine. IMV’s DepoVax platfrom is a patented vaccine delivery formulation that provides controlled and prolonged exposure of antigens adjuvant to the immune system. It offers products for the treatment of breast cancer, ovarian cancer, prostste cancer, malaria, and anthrax. The company partners with Pfizer, MERCK, NIH, Animal Health, and DALHOUSE UNIVERSITY. The company was formerly known as Rhino Resources Inc. IMV is headquartered in Halifax, Nova Scotia, Canada.

Immunovaccine, Inc. Key Recent Developments

Jan 07, 2015: Immunovaccine to Present at 7th Annual Biotech Showcase Conference
Dec 16, 2013: Immunovaccine Elects Marc Mansour, Ph.D. to Board of Directors
Nov 29, 2013: Immunovaccine Announces Financial Results for Quarter Ended September 30, 2013
Nov 21, 2013: Immunovaccine raises $4.2 million in private placement
Sep 03, 2013: Immunovaccine Announces Management Team Changes

This comprehensive SWOT profile of Immunovaccine, Inc. provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Immunovaccine, Inc. including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Immunovaccine, Inc. – Key Information
Immunovaccine, Inc. – Overview
Immunovaccine, Inc. – Key Employees
Immunovaccine, Inc. – Key Employee Biographies
Immunovaccine, Inc. – Key Operational Heads
Immunovaccine, Inc. – Major Products and Services
Immunovaccine, Inc. – History
Immunovaccine, Inc. – Company Statement
Immunovaccine, Inc. – Locations And Subsidiaries
Immunovaccine, Inc. – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Immunovaccine, Inc. – Business Description
Immunovaccine, Inc. – Corporate Strategy
Immunovaccine, Inc. – SWOT Analysis
SWOT Analysis – Overview
Immunovaccine, Inc. – Strengths
Immunovaccine, Inc. – Weaknesses
Immunovaccine, Inc. – Opportunities
Immunovaccine, Inc. – Threats
Immunovaccine, Inc. – Key Competitors

Section 3 – Company Financial Performance Charts

Immunovaccine, Inc. – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Immunovaccine, Inc., Key Information
Immunovaccine, Inc., Key Ratios
Immunovaccine, Inc., Share Data
Immunovaccine, Inc., Major Products and Services
Immunovaccine, Inc., History
Immunovaccine, Inc., Key Employees
Immunovaccine, Inc., Key Employee Biographies
Immunovaccine, Inc., Key Operational Heads
Immunovaccine, Inc., Other Locations
Immunovaccine, Inc., Subsidiaries
Immunovaccine, Inc., Key Manufacturing facilities
Immunovaccine, Inc., Key Competitors
Immunovaccine, Inc., SWOT Analysis
Immunovaccine, Inc., Ratios based on current share price
Immunovaccine, Inc., Annual Ratios
Immunovaccine, Inc., Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Immunovaccine, Inc., Performance Chart
Immunovaccine, Inc., Ratio Charts

★海外企業調査レポート[Immunovaccine, Inc. (IMV):企業概要、財務及び戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Mountainstar Gold Inc. (MSX):企業概要、財務及び戦略的SWOT分析
    Summary Mountainstar Gold Inc. (MGI) is a mineral exploration company. The company acquires and explores gold and other precious metal properties. Its projects include Juneau Project, Oklahoma Natural Gas Properties, Elkhorn Queen Mining Claim and Mina Pascua Mining Claims. MGI has 50% interest in t …
  • SPH REIT Management Pte Ltd:企業の戦略・SWOT・財務分析
    SummarySPH REIT Management Pte Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. …
  • Exelon Generation Company, LLC(エネルギー分野):企業M&A動向
    Summary Exelon Generation Company, LLC (Exelon Generation) is a leading power generation company. The company is a subsidiary of Exelon Corporation, a utility services holding company. Exelon Generation undertakes generation and marketing of electricity for parent entity. It generates electricity fr …
  • Neuralstem, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Neuralstem, Inc. Mergers and Ac …
  • Soho China Limited:企業の戦略・SWOT・財務分析
    SummarySoho China Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Find …
  • Canada Energy Partners Inc. (CE):企業の財務及び戦略的SWOT分析
    Summary Canada Energy Partners Inc. (Canada Energy) is a natural gas exploration company that explores and develops in northeastern British Columbia. The company offers services such as exploration, acquiring, developing and producing of natural gas and coal bed methane, among others. It provides ex …
  • INGKA Holding BV:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' INGKA Holding BV Mergers and Ac …
  • CH2M HILL Companies, Ltd.:企業の戦略・SWOT・財務分析
    SummaryCH2M HILL Companies, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. K …
  • Triphase Accelerator Corp:企業のM&A・提携動向(医療分野)
    Summary Triphase Accelerator Corp (Triphase Accelerator) is a drug development company that acquires and develops cancer therapies from pre-investigational new drug (pre-IND) stage to Phase I or Phase II proof of concept (POC) stage. It pipeline portfolio consists of Marizomib, a proteasome inhibito …
  • Tri-anim Health Services, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Tri-anim Health Services, Inc. …
  • Erasmus MC:企業のM&A・提携動向(医療機器分野)
    Summary Erasmus MC (Erasmus) is a medical institute that offers educational programs such as graduate and doctoral programs in health sciences, biomedical sciences, molecular medicine and cardiovascular sciences through its graduate school, besides others. Erasmus offers patient care, education and …
  • RainDance Technologies, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' RainDance Technologies, Inc. Me …
  • Arion banki hf.の企業概要及びSWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "Arion banki hf." The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. World Market Intelligence s …
  • Sunstone Hotel Investors Inc:戦略・SWOT・企業財務分析
    Sunstone Hotel Investors Inc - Strategy, SWOT and Corporate Finance Report Summary Sunstone Hotel Investors Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Providence Resources plc (PZQA):企業のM&A・提携動向(石油・ガス分野)
    Summary Providence Resources plc (Providence Resource) is an upstream oil and gas company that explores and develops hydrocarbon assets. The company has projects in Ireland and UK including Northern Porcupine basin, Southern Porcupine basin, Goban Spur basin, Saint George's channel basin, and others …
  • IVF Hartmann Holding AG (VBSN):企業の財務及び戦略的SWOT分析
    Summary IVF Hartmann Holding AG (IVF Hartmann), a subsidiary of Paul Hartmann AG is a medical device company that offers patient care products and services. The company develops, produces, and markets medical, pharmaceutical and hygiene products to the healthcare market. Its product segments include …
  • Formula Systems (1985), Ltd.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Formula Systems (1985), Ltd. Me …
  • Hyundai Motor Co (005380)-エネルギー分野:企業M&A・提携分析
    Summary Hyundai Motor Company (Hyundai) is a global manufacturer of automobiles, which designs, develops and manufactures passenger and heavy duty automobiles and relevant parts. The company manufactures passenger cars under various brand names such as Centennial, Genesis, Veloster, Azera, Sonata, i …
  • Abano Healthcare Group Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Abano Healthcare Group Limited …
  • Sloman Neptun Schiffahrts-AG (NEP):企業概要、財務及び戦略的SWOT分析
    Summary SLOMAN NEPTUN Schiffahrts-Aktiengesellschaft (SLOMAN NEPTUN) is a shipping company. The company provides transportation services. It has twenty two modern tankers which serve the global gas and product oil markets, and four multipurpose vessels which connect North Africa and other Mediterran …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆